Cell-To-Cell Signaling |
Synaptic Depression/Neurotransmission |
1.65E-04 |
CAMK2B, ARF1, ITSN1, DGKI, PRKAR1B, EPHB1
|
1.94E-10 |
21 |
Nervous System Development and Function |
Neuritogenesis/Extension of Neurites |
8.40E-03 |
CAMK2B, ST8SIA1, ITSN1, SS18L1, BCL11B, EZR, SLIT3, UST, EPHB1, SRGAP2
|
4.92E-16 |
62 |
Behavior |
Locomotion |
3.09E-04 |
RASD2, HINT1, MC3R, BTBD9, NCF1, CACNA1C, JPH3, FIG4, TAL1
|
1.08E-13 |
40 |
|
Learning |
2.22E-02 |
CAMK2B, NCF1, BTBD9, DGKI, CACNA1C, PRKAR1B, JPH3
|
3.51E-21 |
57 |
Neurological Disease |
Cell Death of Cerebral Cortex Cells |
1.33E-02 |
ST8SIA1, ITSN1, MAP3K11, NCF1, SH3PXD2A
|
8.55E-14 |
32 |
|
Movement Disorder |
4.68E-02 |
CAMK2B, AEBP1, CDS1, ST8SIA1, HINT1, BCL11B, TFAP2B, PDE6C, USP36, RASD2, MC3R, BTBD9, CACNA1C
|
5.58E-32 |
117 |
Lipid Metabolism |
Quantity of Sphingolipid/Steroid |
2.73E-03 |
ST8SIA1, HINT1, BCL11B, PON2
|
4.24E-09 |
40 |
Molecular Transport |
Quantity of Heavy Metal |
1.13E-02 |
ARF1, USF2, COMMD1
|
4.32E-19 |
58 |
|
Transport of Molecule |
1.92E-02 |
SLC5A1, SLC38A1
|
5.41E-31 |
144 |